Many Breast Cancer Patients Can Safely Skip Chemo, Large Trial Confirms

A large study confirms that many patients with early-stage breast cancer don’t need chemotherapy after surgery. The TAILORx trial evaluated a pathology test called OncotypeDx (Genomics Health), which predicts risk of recurrence, and found the test to be reliable.